From $4.5 Billion To NOTHING In One Year. The Disastrous Fall Of Theranos CEO Elizabeth Holmes

About From $4.5 Billion To NOTHING In One Year. The Disastrous Fall Of Theranos CEO Elizabeth Holmes

From $4.5 Billion To NOTHING In One Year. The Disastrous Fall Of Theranos CEO Elizabeth Holmes

Elizabeth Holmes was a revolutionary entrepreneur who made waves in the medical industry. She famously dropped out of Stanford to found a blood testing company that promised to revolutionize the industry. Unfortunately, her story has since taken a turn for the worse, as her company has been accused of fraud and she has been indicted on multiple charges.
From $4.5 Billion To NOTHING In One Year. The Disastrous Fall Of Theranos CEO Elizabeth Holmes is a member of Billionaire News

💰 Net worth: Under Review

Some From $4.5 Billion To NOTHING In One Year. The Disastrous Fall Of Theranos CEO Elizabeth Holmes images

She named the company Theranos, which was a combination of the words therapy and diagnosis.

Elizabeth's idea was that blood taken from a simple prick of the finger could be used to test for thousands of diseases. This was a far less intrusive form of diagnosis then the traditional needle-based blood sample. On the backs of a whirlwind of hype, Theranos raised a massive amount of money and eventually achieved a private valuation of $9 billion. As the 50% owner of the company, the 32-year-old Elizabeth Holmes' paper net worth rocketed to $4.5 billion. She was the world's youngest self-made female billionaire. She appeared on dozens of magazine covers, and received countless awards and honors.

That was one year ago. Today, her fortune is ZERO and her name is mud. Here's how it all went down… WAY DOWN.

Lisa Lake/Getty Images

Last fall, Theranos ran into trouble when it was revealed that the company was exaggerating the results of their technology. Several former patients who've used the Theranos tests in Walgreens Wellness Centers received very inaccurate results. This made the company the subject of a criminal investigation. Theranos is accused of putting 81 people in danger by failing to disclose a problem with a specific hematology test.

Last month, Theranos was forced to void two years worth of blood test results. Now, the company may be facing a full on ban from blood testing from the federal regulators.

A dozen venture capitalists, industry analysts, and experts took a look at the whole Theranos mess and came to the conclusion that a more realistic valuation for the company was $800 million, not $9 billion. That $800 million gives the company credit for its intellectual property as well as the $724 million in funding it has raised.

Holmes 50% stake in Theranos is all common stock. That means that if the company sold tomorrow, Holmes would get paid out AFTER her investors, all of whom own preferred shares. The sad truth, is that if Theranos were completely liquidated today, when it was all said and done, Elizabeth wouldn't receive one dime.

That's a fairly steep drop from being worth $4.5 billion a year ago. Not to mention the psychological damage Elizabeth must be feeling today.